Medical Advisor / MSL Director USA

Waiv, formerly Owkin Dx

About The Position

We are looking for a senior Medical Advisor / MSL Director to serve as the scientific and clinical backbone of one of our flagship AI-based SaMD product lines in the breast cancer space. This is a lifecycle role - spanning evidence generation, KOL engagement, clinical deployment, and regulatory support - with a dual geographic footprint: a US base with hands-on responsibility for EU-facing activities and a supporting remit for US-based medical insights related to a complementary solution and portfolio 1. Product Lifecycle - Medical Leadership Own the end-to-end medical strategy for the assigned breast cancer AI-based prognostic solution, from evidence generation through clinical adoption Drive the scientific narrative: translate clinical data into compelling, rigorous medical communications for internal and external audiences Monitor competitive landscape and clinical guidelines in early breast cancer; identify and communicate implications for product positioning Contribute to claims development, and regulatory submissions in partnership with RAQA and Product and Clinical affairs 2. Clinical Evidence Generation Co-develop and review study protocols, statistical analysis plans, and clinical study reports for prospective and retrospective validation studies Contribute medical perspective to abstract and manuscript preparation; coordinate author relationships and publication planning Interface with internal teams and external partners to ensure medical accuracy of analytical outputs 3. KOL Engagement & Scientific Exchange Build and maintain high-value relationships with breast oncologists, pathologists,and surgeons across North America and Europe Serve as the scientific face of Waiv at key congresses and symposia; deliver medical education and facilitate advisory boards Identify clinical champions and research collaborators; co-develop investigator-initiated research frameworks Gather and synthesize field-based medical insights; systematically feed clinical intelligence back into Product, Portfolio and R&D strategy Support HTA-adjacent discussions and country-level evidence requirements in collaboration with Market Access 4. US Medical Insights — Secondary Product Cover US-based medical insights and KOL engagement activities for a complementary AI-based breast cancer prescreening tool Identify US-specific clinical practice patterns, unmet needs, and evidence gaps relevant to prescreening and genetic testing workflows Relay field intelligence to the core Medical Affairs and Product team for integration into strategy and evidence planning 5. Cross-functional Collaboration Collaborate closely with: Medical Affairs team, Commercial team, VP Pathology, Market Access, and R&D/Biostatistics, Marketing Contribute to board-level and investor-facing scientific communications as required Support Medical Affairs team capacity and knowledge-sharing on breast cancer science and medical device regulatory context

Responsibilities

  • Own the end-to-end medical strategy for the assigned breast cancer AI-based prognostic solution, from evidence generation through clinical adoption
  • Drive the scientific narrative: translate clinical data into compelling, rigorous medical communications for internal and external audiences
  • Monitor competitive landscape and clinical guidelines in early breast cancer; identify and communicate implications for product positioning
  • Contribute to claims development, and regulatory submissions in partnership with RAQA and Product and Clinical affairs
  • Co-develop and review study protocols, statistical analysis plans, and clinical study reports for prospective and retrospective validation studies
  • Contribute medical perspective to abstract and manuscript preparation; coordinate author relationships and publication planning
  • Interface with internal teams and external partners to ensure medical accuracy of analytical outputs
  • Build and maintain high-value relationships with breast oncologists, pathologists,and surgeons across North America and Europe
  • Serve as the scientific face of Waiv at key congresses and symposia; deliver medical education and facilitate advisory boards
  • Identify clinical champions and research collaborators; co-develop investigator-initiated research frameworks
  • Gather and synthesize field-based medical insights; systematically feed clinical intelligence back into Product, Portfolio and R&D strategy
  • Support HTA-adjacent discussions and country-level evidence requirements in collaboration with Market Access
  • Cover US-based medical insights and KOL engagement activities for a complementary AI-based breast cancer prescreening tool
  • Identify US-specific clinical practice patterns, unmet needs, and evidence gaps relevant to prescreening and genetic testing workflows
  • Relay field intelligence to the core Medical Affairs and Product team for integration into strategy and evidence planning
  • Collaborate closely with: Medical Affairs team, Commercial team, VP Pathology, Market Access, and R&D/Biostatistics, Marketing
  • Contribute to board-level and investor-facing scientific communications as required
  • Support Medical Affairs team capacity and knowledge-sharing on breast cancer science and medical device regulatory context
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service